Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Potassium nitrate + stannous fluoride** is an investigational fixed-dose desensitizing dentifrice combining potassium nitrate and stannous fluoride for relief of dentin hypersensitivity. Potassium ions are intended to reduce dentinal sensory-nerve excitability, while stannous fluoride deposits tin-containing material on exposed dentin and within dentinal tubules, helping occlude fluid pathways that trigger pain; fluoride also supports enamel and dentin remineralization. GSK evaluated an experimental formulation containing 5% potassium nitrate and 0.454% stannous fluoride, and Haleon has subsequently registered a study comparing the dual-active dentifrice with single-active and vehicle controls for dentin hypersensitivity. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07215767))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium nitrate + stannous fluoride.